Bago Group

What Bago Group does

Laboratorios Bagó S.A. is an Argentine pharmaceutical company founded in 1934, headquartered in Buenos Aires, with manufacturing operations in La Plata. The company develops, manufactures, and distributes prescription pharmaceutical products, over-the-counter (OTC) consumer health products, the Bagóvit skincare line, and the Bagó+ vitamin supplement line. Its R&D operation is anchored by 148 granted patents (including 56 original molecule discoveries and 92 manufacturing procedure patents) and more than 100 active R&D projects that use AI, pharmacometric tools, and in vitro and in silico methodologies. In December 2025 the company inaugurated an ANMAT-approved Bioanalytical Center at its La Plata plant, joining a select group of six such authorized centers in Argentina for bioequivalence studies.

The company's revenue model combines prescription pharmaceutical sales (promoted through a medical representative sales force targeting physicians and pharmacists), OTC and consumer health distribution through pharmacy retail, and international export to multiple countries including markets in Asia. Customer segments span healthcare professionals (physicians, pharmacists), end consumers of OTC and supplement products, and healthcare institutions engaging in pharmacovigilance and institutional programs. The company maintains three operating sub-brands — Bagóvit (skincare), Bagó+ (vitamins), and Bagó Innova (digital medical education platform for healthcare professionals) — and has extended into medical technology through a 2021 partnership with FIUNER to develop a long-term Holter cardiac monitoring device. Bagó is the #1-ranked pharmaceutical company in Argentina by corporate reputation (MERCO), #14th among the country's 100 most prestigious companies, and operates with 5,001-10,000 employees.

Name

Bago Group

Legal name

Laboratorios Bagó S.A.

Website

https://bago.com.ar

Company type

Private

Founded year

1934

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Laboratorios Bagó is an Argentine pharmaceutical company founded in 1934 that develops and manufactures prescription drugs, OTC consumer health products (Bagóvit, Bagó+), and is expanding into medical technology. It serves physicians, pharmacists, patients, and healthcare institutions primarily in Argentina with exports to multiple countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

akta.pro secondary industries

OTC Medicines & Consumer Health Products Distribution (CRAOAHAB), Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal) (CRADAMAF)

Keywords

• Prescription pharmaceuticals
• Over-the-counter medications
• Pharmaceutical manufacturing
• Dermatological skincare
• Vitamin supplements

Headquarters

HQ city

Buenos Aires

HQ country

Argentina

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Prescription Pharmaceutical Products: Research-based pharmaceutical products sold through medical prescriptions, representing the core business of Laboratorios Bagó. Products span multiple therapeutic areas including cardiovascular, neurological, and general healthcare.
2. Over-the-Counter (OTC) Products: Consumer health products including Bagóvit skincare line and Bagó+ vitamin supplements sold directly through pharmacies and retail channels.
3. Bagóvit Skincare: Dermatological and cosmetic products including Bagóvit Efecto Luminoso cream and other skincare formulations sold through pharmacies.
4. Bagó+ Vitamin Supplements: Vitamin supplement line launched in 2021 for maintaining wellbeing and health balance across different life stages.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Laboratorios Bagó researches, develops, manufactures, and commercializes pharmaceutical products spanning prescription medications and over-the-counter consumer health items across multiple therapeutic areas including cardiovascular, neurological, and dermatological. The company also markets proprietary OTC brands such as Bagóvit skincare and Bagó+ vitamin supplements through Argentine pharmacies, and exports its products internationally. It supports its portfolio with a 148-patent R&D engine, an ANMAT-approved Bioanalytical Center for bioequivalence studies, and the Bagó Innova digital platform serving healthcare professionals.

Differentiator

Problem solved

Functional benefit

Brands

• Bagóvit: Over-the-counter skincare product line including creams like Bagóvit Efecto Luminoso (Light Effect) with mineral pigments, carotenoids, and vitamin A for skin illumination and hydration.
• Bagó+
• Bagó Innova

Products and services

• Prescription Pharmaceutical Products Prescription-only pharmaceutical products distributed through medical representatives and pharmacy networks, spanning cardiovascular, neurological, and general healthcare therapeutic areas for physicians and patients.
• Over-the-Counter (OTC) Pharmaceutical Products Non-prescription pharmaceutical and consumer health products sold directly to consumers through Argentine pharmacy chains and independent pharmacies.
• Bagó+ Vitamin Supplements Line of vitamin supplements designed for maintaining well-being and health balance across different life stages, sold through Argentine pharmacies with Laboratorios Bagó's scientific backing.
• Bagóvit Skincare Line Dermatological and cosmetic products including the Bagóvit Efecto Luminoso cream, featuring ultra-light, hypoallergenic, paraben-free formula with illuminating mineral pigments, carotenoids, vitamin A, and maca/ginger extract, sold through Argentine pharmacies.

Quantifiable outcome

• 6th ANMAT-authorized bioanalytical center in Argentina
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• FIUNER (Facultad de Ingeniería, Universidad Nacional de Entre Ríos)coreStrategic or Co-development Partner · 1 May 2021Partnership with FIUNER to design and prototype a long-term Electrocardiographic Signal Recording System (Holter) with 15-30 day duration capability. The agreement represents Laboratorios Bagó's first medical technology development project as part of its new Health Application Technologies division. Electronic and firmware development conducted at FIUNER's Prototyping Laboratory.
• INTA (Instituto Nacional de Tecnología Agropecuaria)coreStrategic or Co-development Partner · 1 February 2021Partnership with INTA (Argentine Agency in Agriculture and Livestock Technology) for joint COVID-19 research. INTA contributed expertise in agricultural and livestock nanotechnology and biotechnology research while Laboratorios Bagó contributed its commitment to innovation to tackle the pandemic through vaccine development research.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Elea Pharmaceuticals: Argentine pharmaceutical company focused on branded generics and women's health, with regional export presence; competes with Bagó in pharmacy distribution and several shared therapeutic categories.
• Laboratorios Roemmers: Argentina's largest domestically owned pharmaceutical company, founded in 1921, with a comparable portfolio of branded prescription and OTC products, domestic manufacturing, and regional export presence — the closest direct competitor to Bagó in the Argentine pharma market.
• Laboratorios Gador: Argentine pharmaceutical manufacturer with a strong branded generics and innovative drug portfolio, also exporting across Latin America; competes head-to-head with Bagó in cardiology, neurology, and central nervous system therapeutic areas.
• Laboratorios Richmond: Argentine pharmaceutical company with a focus on branded generics, biotechnology (notably viral vector and mRNA platforms), and contract manufacturing — overlapping with Bagó on prescription pharma and now expanding into biologics where Bagó also has R&D ambitions.
• Biol (Laboratorios BIOL): Argentine generics manufacturer with strong ANMAT regulatory standing and export activity, including biosimilars; competes with Bagó's generics and bioequivalence pipeline for the same physician and pharmacy channels.
• Laboratorios Montpellier: Mid-sized Argentine pharmaceutical company with a portfolio in neurology, psychiatry, and OTC consumer health — a regional peer overlapping Bagó's therapeutic areas and consumer brands such as Bagóvit.

Broad incumbents

• Eurofarma Laboratórios: Brazilian multinational pharmaceutical company with broad prescription, OTC, generics, and CDMO operations across Latin America — competes with Bagó in export markets and offers similar vertically integrated manufacturing scale.
• Genomma Lab Internacional: Latin American OTC and personal care leader with a portfolio of consumer health brands sold across the region — the primary competitive benchmark for Bagó's Bagóvit skincare and Bagó+ vitamin sub-brands.
• Bayer (Consumer Health / Pharma): Global pharmaceutical and consumer health major with a deep presence in Argentina across Rx, OTC, vitamins and dermatology — overlaps Bagó across virtually every category but at materially greater scale and marketing investment.

Others

• Procavi (Grupo Bagó subsidiary): Group-level consumer brand referenced under "Pacientes" on Bagó's site; relevant as a sibling channel for consumer health distribution rather than a direct competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks3 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@bagoinnovatv
• Facebookfacebook.com/laboratoriosbagoarg
• LinkedInlinkedin.com/company/laboratorios_bago
• Instagraminstagram.com/laboratoriosbago.arg

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bago Group